Moureau-Zabotto L, Thomas L, Bui B-N, Chevreau C, Stockle E, Martel P, Bonneviale P, Marques B, Coindre J-M, Kantor G, Matsuda T, Delannes M
Département d'oncologie radiothérapie, institut Clandius-Regaud, Toulouse, France.
Cancer Radiother. 2004 Oct;8(5):279-87. doi: 10.1016/j.canrad.2004.07.004.
To analyse the management and clinical outcome of patients treated for a first isolated local recurrence of soft tissue sarcoma (trunk or extremities) and to identify prognosis factors.
This is a retrospective study of 83 adult patients treated between 1980 and 1999. Mean tumor size was 6 cm. Most sarcomas were located in extremities (N =74), were deep (N =60), and proximal (N =53). Thirty involved nerves or vessels. Histologic subtypes were mainly grade 2 (42%) or 3 (36%) histocytofibrosarcomas (49%) and liposarcomas (20%). Surgical treatment of recurrences consisted in wide excision (32 cases), marginal resection (46 cases), five patients requiring amputation. Final results were R0 (N =33), R1 (N =47) or R2 (N =3) resection. Beside surgery, six patients received neoadjuvant and seven others adjuvant chemotherapy. Twenty-three patients received postoperative external beam radiotherapy (EBRT) (mean dose 55 Gy) and 26 interstitial (192)Ir low dose rate brachytherapy (BCT) (mean dose 45 Gy for BCT alone, 22 Gy when associated with EBRT), 19 patients being re-irradiated.
Mean follow up was 59 months. Thirty-seven (45%) tumors relapsed, 62% locally as first event. Nineteen patients developed secondary distant metastases. Multivariate analysis showed only tumour depth (P =0.05) and re-resection for primary R1 resection for the recurrence (P =0.018) being independent prognosis factors for tumour control, radiotherapy (EBRT and/or BCT) being significant in univariate analysis (P =0.05). Overall survival rate was 73, 54, and 47% at respectively 3, 5 and 10 years, and was 65, 35 and 32% after a further local recurrence. Multivariate analysis showed trunk (P =0.0001) or inferior extremity locations (P =0.023), symptomatic (P =0.001), high grade (P =0.01), deep (P = 0.01) tumours, and the occurrence of a further local failure (P =0.004) as unfavourable characteristics for overall survival.
Because of the high relapse rate in this series, a first isolated local recurrence of STS increases mainly the risk of a subsequent local relapse. Quality of local treatment for the first local relapse is decisive. When a conservative treatment is feasible, it should combine surgical resection and radiotherapy, brachytherapy being the best suited in previously irradiated patients. Efforts have to be pursued to increase quality of the treatment of primary tumours, at best performed in centers that have expertise in this field.
分析首次孤立性局部复发的软组织肉瘤(躯干或四肢)患者的治疗及临床结局,并确定预后因素。
这是一项对1980年至1999年间接受治疗的83例成年患者的回顾性研究。肿瘤平均大小为6厘米。大多数肉瘤位于四肢(n = 74),位置较深(n = 60),且位于近端(n = 53)。30例累及神经或血管。组织学亚型主要为2级(42%)或3级(36%)的组织细胞纤维肉瘤(49%)和脂肪肉瘤(20%)。复发病灶的手术治疗包括广泛切除(32例)、边缘切除(46例),5例患者需要截肢。最终切除结果为R0(n = 33)、R1(n = 47)或R2(n = 3)。除手术外,6例患者接受了新辅助化疗,7例接受了辅助化疗。23例患者接受了术后外照射放疗(EBRT)(平均剂量55 Gy),26例接受了组织间(192)铱近距离低剂量率放疗(BCT)(单纯BCT平均剂量45 Gy,与EBRT联合时为22 Gy),19例患者接受了再次放疗。
平均随访59个月。37例(45%)肿瘤复发,62%的首次复发为局部复发。19例患者出现继发性远处转移。多因素分析显示,仅肿瘤深度(P = 0.05)和首次复发时对原发性R1切除进行再次切除(P = 0.018)是肿瘤控制的独立预后因素,放疗(EBRT和/或BCT)在单因素分析中具有显著意义(P = 0.05)。3年、5年和10年的总生存率分别为73%、54%和47%,在再次局部复发后的总生存率分别为65%、35%和32%。多因素分析显示,躯干(P = 0.0001)或下肢部位(P = 0.023)、有症状(P = 0.001)、高级别(P = 0.01)、位置较深(P = 0.01)的肿瘤以及再次出现局部复发(P = 0.004)是总生存的不利特征。
由于本系列研究中复发率较高,首次孤立性局部复发的软组织肉瘤主要增加了随后局部复发的风险。首次局部复发的局部治疗质量起决定性作用。当可行保守治疗时,应将手术切除与放疗相结合,近距离放疗最适合曾接受过放疗的患者。必须努力提高原发性肿瘤的治疗质量,最好在该领域具有专业知识的中心进行治疗。